Table 1.
Study details (Author, year, country) |
Sample Characteristics (n) |
Treatment ‐Drug ‐dose/day ‐via of admin. ‐duration |
Study design | Sequencing method | Results | Author's conclusion | |
---|---|---|---|---|---|---|---|
Taxonomy | Diversity | ||||||
Human studies | |||||||
Sun et al, 2018, China 35 | Men, with newly diagnosed hypercholesterolemia (202) |
Atorvastatin, 20mg, Oral, 12 wk |
»Blood LDLc was measured at wk 0, 4 and 12. »Fecal samples collected at week 0. »At the end of treatment, subjects divided in two groups based on their LDLc levels: group SS < 100 mg/dL; group SR ≥ 100 mg/dL. |
Amplification by PCR of the V3‐V4 regions of 16S rRNA gene. |
Phylum »group SS: higher proportions of Firmicutes Genus »group SS: higher proportions of Lactobacillus, Eubacterium, Faecalibacterium and Bifidobacterium.»group SR: higher proportions of Clostridium |
Group SS: greater bacterial diversity than SR group. | Higher GM diversity is associated with statin sensitive response. |
Liu et al, 2018, China 36 | Men (45) and women (19), with primary hypercholesterolemia b |
Rosuvastatin, 10mg, Oral, 4 to 8 wk |
»Blood LDLc, HDLc, TG and Tc were measured at wk 0, 4 and 8. »Fecal samples collected at wk 0. »Subjects were divided in two groups based on their BLL: group 1 if BLL dropped to normal levels from wk 4; group 2 if BLL still above normal levels after 8 wk. |
Amplification by PCR of the V3‐V4 regions of 16S rRNA gene. |
Phylum »group 1: higher proportions of Firmicutes »group 2: increased proportions of Actinobacteria Family »group 1: higher proportions of Ruminococcaceae, Lactobacillaceae and Bifidobacteriaceae »group 2: increased proportions of Bacteroidaceae, Pseudomonaceae, Streptococcaceae, Enterobacteriaceae, and other endotoxin‐producing bacteria |
Alpha diversity»group I: higher diversity than group II. Beta diversity both groups presented a much different GM composition. |
Higher diversity in GM composition was linked to RSV hypolipidemic effect. |
Animal studies | |||||||
He et al, 2018, China 38 | Male C57BL/6J mice (60) |
Simvastatin, 20 mg Kg‐1 BW, Oral, 4 wk |
»Random selection of control group (n = 7) and intervention group (n = 53). »Control group: fed with NCD; intervention group fed with HFD; both for 8 wk. »Then intervention group was further divided into 4 different treatment groups: HFD (n = 8); AB (n = 10), SV (n = 13), and AB_SV (n = 12). *HFD group was given high fat diet, for 4 wk *AB and AB_SV groups received imipenem/cilastatin 100 mg/Kg id, for 4 wk *AB_SV and SV groups received simvastatin, for 4 wk »Blood LDLc, HDLc, TG and Tc, and cecal samples were collected at wk 4. |
Amplification by PCR of the V3‐V4 regions of 16S rRNA gene. |
Phylum »groups AB and AB_SV: higher proportions of Proteobacteria than other 3 groups (control, HFD and SV). »groups AB and AB_SV: decreased proportions of Bacteroidetes and Firmicutes. |
Alpha diversity »data not shown Beta diversity »groups AB and AB_SV: distinct GM composition than the other 3 groups. |
Hypolipidemic effect of SV might be associated with some metabolic pathways which, in turn, could be impaired by GM modulation. |
Wang et al, 2018, China 39 | Male SPF SD rats 45 |
Rosuvastatin, 10 mg Kg−1 BW, Oral, 4 wk |
»Random selection of AB_Statin group (n = 10), Statin group (n = 10), and Water group (n = 10). »Initially AB_Statin group received ceftriaxone (2gr/Kg BW bid) for 8 days to establish a dysbiotic rat model »Then AB_Statin and Statin groups were given rosuvastatin, for 4 wk »Water group was given saline solution 2id, for 4 wk »Blood LDLc, HDLc, TG and Tc were measured at wk 0, 2 and 4. »Fecal samples collected at wk 0, 2 and 4 wks. |
Amplification by PCR of the V3‐V4 regions of 16S rRNA gene. | AB_Statin group presented diminished levels of Lactobacillus and Bifidobacterium (genus) than Statin group |
Alpha diversity»AB_Statin group: reduction in bacterial diversity at the beginning compared with Statin and Water groups. At wk 4, no differences in GM diversity between the three groups were shown. Beta diversity AB_Statin group: much different GM composition, while Statin and Water groups had similarities. |
Lipid‐lowering ability of RSV can be affected by a disruptive intestinal flora. |
Abbreviations: AB, Antibiotic; AB_SV, Antibiotic + Simvastatin; BLL, blood lipid levels; BW, Body Weight; GM, Gut Microbiome; HDLc, High Density Lipoprotein cholesterol; HFD, High Fat Diet; LDLc, Low‐Density Lipoprotein cholesterol; NCD, Normal Chow Diet; PCR, Polymerase Chain Reaction; RSV, Rosuvastatin; SR, statin resistant; SS, statin sensible; SV, Simvastatin; TC, Total cholesterol; TG, Triglycerides.
Hypercholesterolemia was considered when serum LDLc ≥ 130 mg/dl.
Hypercholesterolemia was considered when serum LDLc ≥ 3.64 mmol/L (≈140 mg/dl), HDLc ≤ 3.64 mmol/L (≈140 mg/dl), TG ≥ 1.70 mmol/L (≈150 mg/dl), and TC ≥ 5.72 mmol/L (≈220 mg/dl)